The aim of our study was to determine whether the diffusion properties of the
auditory pathways alter between patients with Neurofibromatosis type 1 (NF1) and the healthy subjects. DTI can well demonstrate FA and ADC changes in auditory tracts and it may be a guide to
identify the candidates for hearing loss among NF1 children.
